Extracorporeal membrane oxygenation (ECMO) is increasingly being used for patients with severe acute respiratory failure, with the strongest evidence for its use in patients with very severe forms of acute distress respiratory syndrome (ARDS). However, many questions about how best to optimize the care of ECMO patients remain. Future research should focus on better defining the role and limitations of ECMO.